HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Social Bookmarking                What's this?

The Translating Research Into Action for Diabetes (TRIAD) Study

A multicenter study of diabetes in managed care

Abbreviations: HMO, health maintenance organizations • TRC, translational research center • TRIAD, Translating Research Into Action for Diabetes.

Diabetes presents formidable challenges to the U.S. health care system because of its high prevalence and morbidity and the complexity and cost of managing the disease (1–2). Diabetes complications can be reduced with efficacious treatments, such as glycemic, blood pressure, lipid control and screening, and early treatment for eye, kidney, and foot disease (3–6); however, these treatments are not adequately implemented (7–11). Thus, there is a need to better understand modifiable factors that affect the quality and outcomes of care across diverse health care systems.

The Translating Research Into Action for Diabetes (TRIAD) study uses Donabedian’s classic paradigm for studying quality of care by relating structural factors in health care systems and provider organization to the processes and outcomes of care (12). Because of the proliferation of managed care systems, with various organizational, reimbursement, and disease management approaches (13–20), managed care is a critical setting in which to apply this paradigm. The TRIAD study is a multicenter prospective study that seeks to identify modifiable barriers to optimal diabetes care across diverse managed care settings. This report describes TRIAD’s study hypotheses, objectives, design, participants, and methods.

Study hypotheses

The fundamental hypothesis of the TRIAD study is that structural and organizational characteristics of health systems and health care provider groups affect the processes and quality of care that, in turn, influence health and economic outcomes (Fig. 1). More specifically, the TRIAD study hypothesizes that greater experience with managed care, less use of clinician incentives to limit referrals and care, more intense efforts to implement accepted practice guidelines, and the presence of systems to identify, risk stratify, and manage patients (e.g., via registries, reminder systems, and case managers) will be associated with better processes and outcomes of care. Additionally, more direct patient education, fewer financial barriers (e.g., lower co-payments and greater pharmacy and supplies benefits) and fewer nonfinancial barriers (e.g., communication barriers and lack of a regular provider) will be associated with better processes and outcomes of care. Processes of care include HbA_1c tests; blood pressure and lipid tests; eye, renal, and foot screening; and smoking cessation and health promotion counseling. Primary health outcomes are those associated with diabetes complications (e.g., glycemic control, blood pressure, lipid levels, and microalbuminuria) and impact of the disease (e.g., resource utilization, cost, quality of life, functional status, and patient satisfaction).

View larger version (38K): [in this window] [in a new window]   Figure 1— Conceptual overview of TRIAD and study hypotheses. Detailed predictor-specific, outcome-specific hypotheses and survey instruments are available upon request from the corresponding author.

The TRIAD study is a multicenter prospective cohort study. It includes baseline and 18-month follow-up data collection from health plans, provider groups, and diabetic patients. Structural and health system factors are assessed using standardized in-person interviews of health plan and provider group medical directors and leadership personnel (21). These interviews assess general organizational and financial characteristics (e.g., clinician incentives and management of referral care) as well as diabetes-specific infrastructure and clinical activities (e.g., use of registries, case management, and diabetes-specific guideline use).

Patient data are obtained from surveys, medical record reviews, and administrative data. A patient survey, administered either by computer-assisted telephone interview or in writing, assesses sociodemographic characteristics, recommended diabetes care services received, and general health status and quality of life measures (the 12-item short-form health survey and the 5-item EuroQOL diabetes-specific symptom scale) (22–24). It also assesses access to care, patient satisfaction (the Consumer Assessment of Health Plans Survey), diabetes education received, participation in self-care activities, disease management, and financial barriers (25). The TRIAD study’s medical record review includes data abstracted from paper and electronic medical records during the 18 months before the patient survey. Administrative data are derived from inpatient and outpatient claims and pharmacy and laboratory data provided by the health plans. These data are used to establish the initial sampling frame, measure health services utilization and costs (e.g., hospitalization and ambulatory care visits), and tabulate quality indicators (e.g., laboratory and diagnostic tests and drug prescriptions).

Study centers and participants

The TRIAD study includes six translational research centers (TRCs). These centers collaborate with 10 health plans and 63 provider groups, which serve 180,000 patients with diabetes (Table 1). Managed care health plans are defined as entities that deliver, administer, and/or assume risk for health services to influence quality, access, cost, and outcomes of health care for a defined population (20). Health plans participating in the TRIAD study include staff model health maintenance organizations (HMOs), network/IPA (independent provider association) model HMOs, point-of-service plans, and preferred-provider organizations (Table 1). These plans include for-profit, not-for-profit, Medicare, and Medicaid products. Altogether, 63 provider groups contracting with the TRIAD study’s partner health plans were also recruited into the study. For the TRIAD study, a provider group has considerable autonomy, determines compensation arrangements and financial incentives with physicians, and may be directly engaged in diabetes care management, as well as controlling access to specialty and referral care.

Conclusions

Because effective diabetes management requires complex integration of primary, specialty, and self-care, diabetes presents numerous challenges to managed care plans to provide high-quality, cost-effective care. Because managed care systems are so heterogeneous, little is known about how health plan benefits, physician payment mechanisms and financial incentives, and approaches to influence the management of primary care and referral care affect diabetes care and outcomes (13–15). Similarly, managed care organizations have used numerous approaches for diabetes disease management programs, including computerized registries to identify high-risk patients, nurse case management, telephone contact, computerized reminder systems, group visits, and diabetes education (16–20). However, evaluation of the effects of these strategies on the processes or outcomes of care across diverse systems and subgroups of patients is extremely limited. Finally, the TRIAD study will examine the extent to which patient-level financial (e.g., insurance costs, level of copayment, patient access, and expenses related to medications, supplies, education and specialist visits) and nonfinancial barriers (e.g., culturally appropriate health promotion counseling) affect care and outcomes (26,27).

In summary, the TRIAD study is a multicenter study designed to determine how the structure and organization of managed care systems influence the processes and outcomes of diabetes care. These factors include general organizational characteristics, as well as infrastructure and activities designed specifically for diabetes. Factors will range from those acting at the health plan level to those acting at the individual patient level. By linking information from health plans, provider groups, and patients across a wide range of models of care and diverse populations, the TRIAD study offers unique opportunities to improve understanding of both the facilitators and barriers to diabetes care in a variety of managed care settings and a rich diversity of patients. These findings should be useful for diabetes and other chronic disease management programs.

APPENDIX

The TRIAD Study Group
Pacific Health Research Institute.
Principal investigator: J. David Curb, MD, MPH. Co-investigators: Beth Waitzfelder, MA; Richard Chung, MD (Hawaii Medical Service Association [HMSA]); Peggy Latare, MD (Kaiser Permanente Hawaii [KPH]); Lynette Honbo, MD (Hawaii State Department of Human Services [HDHS]); R. Adam Dudley, MD, MB (University of California, San Francisco); Beatriz Rodriguez, MD, PhD; and Robert Abbott, PhD. Consultant: Joseph Humphry, MD (HMSA). Analysts: Rebecca Glavan; Andrew White, PhD (HMSA); Ken Forbes (KPH); and James Cooper, MA (HDHS). Administrative assistants: Ruth Baldino and Esther Nakano.

Indiana University Translational Research Center.
Principal investigator: David G. Marrero, PhD. Project coordinator: Susanna R. Williams, MSPH. Co-investigators: Morris Weinberger, PhD; William M. Tierney, MD; and M. Sue Kirkman, MD.

Kaiser Foundation Research Institute.
Principal investigator and study chairman: Joe V. Selby, MD, MPH. Project director: Bix E. Swain, MS. Co-investigators: Andrew J. Karter, PhD, and Assiamira Ferrara, MD, PhD.

University of California, Los Angeles School of Medicine.
Principal investigator: Carol M. Mangione, MD, MSPH. Co-principal investigator: Arleen F. Brown, MD. Project director: Rebecca Brusuelas. Co-investigators: Martin F. Shapiro, MD, PhD; Susan Ettner, PhD; and Sam Ho, MD (PacifiCare Health Systems). Data analysts: Peter R. Gutierrez and Neil Steers, PhD. Senior administrator: Carole Nagy.

University of Medicine and Dentistry of New Jersey.
Principal investigator: Monika M. Safford, MD. Co-investigators: Dorothy A. Caputo, MA, RNC, CDE; Michael Brimacombe, PhD; David Hom, MS; David Kountz, MD; Leonard Pogach, MD, MBA; Louise Russell, PhD; Quanwu Zhang, PhD; David Bendich, MD (Horizon Blue Cross Blue Shield); Joseph Singer, MD; John Chard, MD; and Ron Snyder, MD (Healthnet). TRIAD-wide administrative assistant: Gabrielle Davis, BA.

The University of Michigan Health System.
Principal investigator: William H. Herman, MD, MPH. Project director: Jennifer Goewey, MHA. Programmer/analyst: Diane Averill. Research associates: Ray Burke, MA; Bahman Tabaei, MPH; and Honghong Zhou. Administrative assistants: William Sowab and Kelly Fearer.

Social & Behavioral Research Institute, California State University San Marcos.
Richard Serpe, PhD, and Allen J. Risley, MS.

Klemm Analysis Group.
David N. Cowan, PhD, MPH, and Tonya D. Samuel, MS.

National Institute of Diabetes and Digestive and Kidney Diseases.
Sanford A. Garfield, PhD.

Division of Diabetes Translation, Centers for Disease Control and Prevention.
Principal scientist: K.M. Venkat Narayan, MD, MSc, MBA. Project administrator: Bernice Moore, MBA. Co-scientists: Theodore Thompson, MS; Edward W. Gregg, PhD; Robert Gerzoff, MS; Michael M. Engelgau, MD, MS; Gloria Beckles, MBBS, MSc, Patrick Boyle, PhD; and Deborah Rolka, MS.

TRIAD-wide Administrative Data Coordinator: Barbara R.K. Smith, MHSA.

Footnotes

Address correspondence and reprint requests to Edward W. Gregg, PhD, Division of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Hwy., NE, Mailstop K-10, Atlanta, GA 30341. E-mail: edg7{at}cdc.gov.

Received for publication 30 April 2001 and accepted in revised form 4 September 2001.

Members of the TRIAD study group are listed in the appendix.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

References

1. Centers for Disease Control and Prevention: Diabetes Surveillance, 1997. Atlanta, GA, U.S. Department of Health and Human Services, 1997
   
2. American Diabetes Association: Economic consequences of diabetes mellitus in the U.S. Diabetes Care 21:296–309, 1998[Abstract]
   
3. Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, Ford ES, Vinicor F: Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized controlled trial. Ann Intern Med 119:36–41, 1993[Abstract/Free Full Text]
   
4. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998[Medline]
   
5. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. [Published erratum appears in BMJ 318:29, 1999]. BMJ 317:703–713, 1998[Abstract/Free Full Text]
   
6. Javitt JC, Aiello LP, Chiang Y, Ferris FL III, Canner JK, Greenfield S: Preventive eye care in people with diabetes is cost-saving to the federal government: implications for health-care reform. Diabetes Care 17:909–917, 1994[Abstract]
   
7. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22:403–408, 1999[Abstract]
   
8. Harris MI: Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 23:754–758, 2000[Abstract/Free Full Text]
   
9. Martin TL, Selby JV, Zhang D: Physician and patient prevention practices in NIDDM in a large urban managed-care organization. Diabetes Care 18:1124–1132, 1995[Abstract]
   
10. Marrero DG: Current effectiveness of diabetes health care in the United States. How far from the ideal? Diabetes Reviews 2:292–309, 1994
    
11. Centers for Disease Control and Prevention: Levels of diabetes-related preventive care practices-United States, 1997–1999. MMWR 49:954–958, 2000[Medline]
    
12. Donabedian A: The definition of quality. In Explorations in Quality Assessment and Monitoring. Vol. 1. Ann Arbor, MI, Health Administration Press, 1985
    
13. Kerr EA, Mittman BS, Hays RD, Siu AL, Leake B, Brook RH: Managed care and capitation in California. How do physicians at financial risk control their own utilization? Ann Intern Med 123:500–504, 1995[Abstract/Free Full Text]
    
14. Gold MR: Financial incentives: current realities and challenges for physicians (Review). J Gen Intern Med 14:S6–S12, 1999
    
15. Grimshaw JM, Russell IT: Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:1317–1322, 1993[Medline]
    
16. McCulloch DK, Glasgow RE, Hampson SE, Wagner E: A systematic approach to diabetes management in the post-DCCT era (Commentary). Diabetes Care 17:765–769, 1994[Medline]
    
17. Weinberger M, Kirkman MS, Samsa GP, Shortliffe EA, Landsman PB, Cowper PA, Simel DL, Feussner JR: A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life. J Gen Intern Med 10:59–66, 1995[Medline]
    
18. Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, Bailey CM, Koplan JP: Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization: a randomized, controlled trial. Ann Intern Med 129:605–612, 1998[Abstract/Free Full Text]
    
19. Piette JD, McPhee SJ, Weinberger M, Mah CA, Kraemer FB: Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes. Diabetes Care 22:1302–1309, 1999[Abstract]
    
20. American Medical Association: Principles of managed care (4th edition), 1999 [Article online]. Available from http://www.ama-assn.org/ama/upload/mm/363/principles.pdf. Accessed 28 November 2001
    
21. Mangione CM, Damberg C, Horst M, Castles A, Gutierrez PR, Brown AF, Spar M, Carlisle D, Kahn KL: Variation by region in the financial and organizational structure of physician groups in California and the Pacific Northwest (Abstract). J Gen Intern Med 15 (Suppl.):133, 2000
    
22. Ware J Jr, Kosinski M, Keller SD: A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233, 1996[Medline]
    
23. Brazier J, Jones N, Kind P: Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 2:169–180, 1993[Medline]
    
24. Testa MA, Simonson DC: Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 280:1490–1496, 1998[Abstract/Free Full Text]
    
25. Hays RD, Shaul JA, Williams VS, Lubalin JS, Harris-Kojetin LD, Sweeny SF, Cleary PD: Psychometric properties of the CAHPS 1.0 survey measures: Consumer Assessment of Health Plans Study. Med Care 37 (Suppl. 3):MS22–MS31, 1997
    
26. Karter AJ, Ferrara A, Darbinian J, Ackerson LM, Selby JV: Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care 23:477–483, 2000[Abstract]
    
27. Selby JV, Fireman BH, Swain BE: Effect of a copayment on use of the emergency department in a health maintenance organization. N Engl J Med 334:635–641, 1996[Abstract/Free Full Text]
    

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				H. H Moffet, N. Adler, D. Schillinger, A. T Ahmed, B. Laraia, J. V Selby, R. Neugebauer, J. Y Liu, M. M Parker, M. Warton, et al. Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population Int. J. Epidemiol., March 7, 2008; (2008) dyn040v1. [Full Text] [PDF]

				L. N. McEwen, N. E. Pomeroy, K. Onyemere, and W. H. Herman Are Primary Care Physicians More Likely to Record Diabetes on Death Certificates? Diabetes Care, March 1, 2008; 31(3): 508 - 510. [Full Text] [PDF]

				A. J. Karter, M. R. Stevens, E. W. Gregg, A. F. Brown, C.-W. Tseng, D. G. Marrero, O. K. Duru, T. L. Gary, J. D. Piette, B. Waitzfelder, et al. Educational Disparities in Rates of Smoking Among Diabetic Adults: The Translating Research Into Action for Diabetes Study Am J Public Health, February 1, 2008; 98(2): 365 - 370. [Abstract] [Full Text] [PDF]

				T. L. Gary, M. M. Safford, R. B. Gerzoff, S. L. Ettner, A. J. Karter, G. L. Beckles, and A. F. Brown Perception of Neighborhood Problems, Health Behaviors, and Diabetes Outcomes Among Adults With Diabetes in Managed Care: The Translating Research Into Action for Diabetes (TRIAD) Study Diabetes Care, February 1, 2008; 31(2): 273 - 278. [Abstract] [Full Text] [PDF]

				A. Ferrara, C. M. Mangione, C. Kim, D. G. Marrero, D. Curb, M. Stevens, J. V. Selby, and for the Translating Research Into Action for Diabe Sex Disparities in Control and Treatment of Modifiable Cardiovascular Disease Risk Factors Among Patients With Diabetes: Translating Research Into Action for Diabetes (TRIAD) Study Diabetes Care, January 1, 2008; 31(1): 69 - 74. [Abstract] [Full Text] [PDF]

				Club Diabete Sicili@ Five-Year Impact of a Continuous Quality Improvement Effort Implemented by a Network of Diabetes Outpatient Clinics Diabetes Care, January 1, 2008; 31(1): 57 - 62. [Abstract] [Full Text] [PDF]

				A. E. Carroll, R. T. Ackermann, E. J. Brizendine, C. Shen, and D. G. Marrero Does Age at Diabetes Diagnosis Influence Long-Term Physical and Behavioral Outcomes? Diabetes Care, November 1, 2007; 30(11): 2859 - 2860. [Full Text] [PDF]

				L. N. McEwen, C. Kim, A. J. Karter, M. N. Haan, D. Ghosh, P. M. Lantz, C. M. Mangione, T. J. Thompson, and W. H. Herman Risk Factors for Mortality Among Patients With Diabetes: The Translating Research Into Action for Diabetes (TRIAD) Study Diabetes Care, July 1, 2007; 30(7): 1736 - 1741. [Abstract] [Full Text] [PDF]

				W. H. Herman Diabetes Epidemiology: Guiding Clinical and Public Health Practice: The Kelly West Award Lecture, 2006 Diabetes Care, July 1, 2007; 30(7): 1912 - 1919. [Full Text] [PDF]

				R. T. Ackermann, T. J. Thompson, J. V. Selby, M. M. Safford, M. Stevens, A. F. Brown, and K.M. V. Narayan Is the Number of Documented Diabetes Process-of-Care Indicators Associated With Cardiometabolic Risk Factor Levels, Patient Satisfaction, or Self-Rated Quality of Diabetes Care?: The Translating Research into Action for Diabetes (TRIAD) study. Diabetes Care, September 1, 2006; 29(9): 2108 - 2113. [Abstract] [Full Text] [PDF]

				S. L. Johnson, E. F. Tierney, K. U. Onyemere, C.-W. Tseng, M. M. Safford, A. J. Karter, A. Ferrara, O. K. Duru, A. F. Brown, K.M. V. Narayan, et al. Who Is Tested for Diabetic Kidney Disease and Who Initiates Treatment?: The Translating Research Into Action for Diabetes (TRIAD) study Diabetes Care, August 1, 2006; 29(8): 1733 - 1738. [Abstract] [Full Text] [PDF]

				C. M. Mangione, R. B. Gerzoff, D. F. Williamson, W. N. Steers, E. A. Kerr, A. F. Brown, B. E. Waitzfelder, D. G. Marrero, R. A. Dudley, C. Kim, et al. The Association between Quality of Care and the Intensity of Diabetes Disease Management Programs Ann Intern Med, July 18, 2006; 145(2): 107 - 116. [Abstract] [Full Text] [PDF]

				L. N. McEwen, C. Kim, M. Haan, D. Ghosh, P. M. Lantz, C. M. Mangione, M. M. Safford, D. Marrero, T. J. Thompson, W. H. Herman, et al. Diabetes Reporting as a Cause of Death: Results from the Translating Research Into Action for Diabetes (TRIAD) study Diabetes Care, February 1, 2006; 29(2): 247 - 253. [Abstract] [Full Text] [PDF]

				A. F. Brown, E. W. Gregg, M. R. Stevens, A. J. Karter, M. Weinberger, M. M. Safford, T. L. Gary, D. A. Caputo, B. Waitzfelder, C. Kim, et al. Race, Ethnicity, Socioeconomic Position, and Quality of Care for Adults With Diabetes Enrolled in Managed Care: The Translating Research Into Action for Diabetes (TRIAD) study Diabetes Care, December 1, 2005; 28(12): 2864 - 2870. [Abstract] [Full Text] [PDF]

				B. P. Tabaei, W. H. Herman, A. F. Jabarin, and C. Kim Does Diabetes Care Compete With the Provision of Women's Preventive Care Services? Diabetes Care, November 1, 2005; 28(11): 2644 - 2649. [Abstract] [Full Text] [PDF]

				S. L. Krein, M. Heisler, J. D. Piette, F. Makki, and E. A. Kerr The Effect of Chronic Pain on Diabetes Patients' Self-Management Diabetes Care, January 1, 2005; 28(1): 65 - 70. [Abstract] [Full Text] [PDF]

				A. Ferrara, D. F. Williamson, A. J. Karter, T. J. Thompson, C. Kim, and for the TRIAD Study Group Sex Differences in Quality of Health Care Related to Ischemic Heart Disease Prevention in Patients With Diabetes: The Translating Research Into Action for Diabetes (TRIAD) study, 2000-2001 Diabetes Care, December 1, 2004; 27(12): 2974 - 2976. [Full Text] [PDF]

				E. A. Kerr, R. B. Gerzoff, S. L. Krein, J. V. Selby, J. D. Piette, J. D. Curb, W. H. Herman, D. G. Marrero, K.M. V. Narayan, M. M. Safford, et al. Diabetes Care Quality in the Veterans Affairs Health Care System and Commercial Managed Care: The TRIAD Study Ann Intern Med, August 17, 2004; 141(4): 272 - 281. [Abstract] [Full Text] [PDF]

				C. Kim, D. F. Williamson, C. M. Mangione, M. M. Safford, J. V. Selby, D. G. Marrero, J. D. Curb, T. J. Thompson, K.M. Venkat Narayan, and W. H. Herman Managed Care Organization and the Quality of Diabetes Care: The Translating Research Into Action for Diabetes (TRIAD) study Diabetes Care, July 1, 2004; 27(7): 1529 - 1534. [Abstract] [Full Text] [PDF]

				K. M. Venkat Narayan, E. Benjamin, E. W. Gregg, S. L. Norris, and M. M. Engelgau Diabetes Translation Research: Where Are We and Where Do We Want To Be? Ann Intern Med, June 1, 2004; 140(11): 958 - 963. [Abstract] [Full Text] [PDF]

				A. F. Brown, R. B. Gerzoff, A. J. Karter, E. Gregg, M. Safford, B. Waitzfelder, G. L. A. Beckles, R. Brusuelas, and C. M. Mangione Health Behaviors and Quality of Care Among Latinos With Diabetes in Managed Care Am J Public Health, October 1, 2003; 93(10): 1694 - 1698. [Abstract] [Full Text] [PDF]

				A. J. Karter, M. R. Stevens, W. H. Herman, S. Ettner, D. G. Marrero, M. M. Safford, M. M. Engelgau, J. D. Curb, and A. F. Brown Out-of-Pocket Costs and Diabetes Preventive Services: The Translating Research Into Action for Diabetes (TRIAD) study Diabetes Care, August 1, 2003; 26(8): 2294 - 2299. [Abstract] [Full Text] [PDF]

				M. Brandle, H. Zhou, B. R.K. Smith, D. Marriott, R. Burke, B. P. Tabaei, M. B. Brown, and W. H. Herman The Direct Medical Cost of Type 2 Diabetes Diabetes Care, August 1, 2003; 26(8): 2300 - 2304. [Abstract] [Full Text] [PDF]

				A. J. Karter, A. Ferrara, J. Y. Liu, H. H. Moffet, L. M. Ackerson, and J. V. Selby Ethnic Disparities in Diabetic Complications in an Insured Population JAMA, May 15, 2002; 287(19): 2519 - 2527. [Abstract] [Full Text] [PDF]

				J. B. Saaddine, M. M. Engelgau, G. L. Beckles, E. W. Gregg, T. J. Thompson, and K.M. V. Narayan A Diabetes Report Card for the United States: Quality of Care in the 1990s Ann Intern Med, April 16, 2002; 136(8): 565 - 574. [Abstract] [Full Text] [PDF]

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Social Bookmarking                What's this?